Ace2 Tmprss2

ACE2 and TMPRSS2 are human proteins that work together in a biochemical pathway used by certain enveloped viruses to enter host cells. ACE2 serves as a cell-surface receptor, while the serine protease TMPRSS2 cleaves viral spike proteins, triggering structural changes that promote fusion between the viral envelope and host-cell membrane. Their coordinated activity is especially relevant in respiratory epithelial cells and provides a framework for studying viral tropism, infection mechanisms, and host susceptibility. Biochemical and cell-based analyses of this pathway also support evaluation of entry inhibitors and other strategies that could limit viral transmission or disease.

Ace2 Tmprss2 - Related Videos

Research

JoVE EoE - Immunodiagnostics

Assessing Functional SARS-CoV-2 Neutralizing Antibodies

0 Views •

2026

Source:Kelly Da Costa1, Diego Cantoni1,2, Martin Mayora-Neto1, Tobia Fantoni1,3, Nigel Temperton11Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent.2MRC-University of Glasgow Centre for Virus Research, University of Glasgow.3Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona.This video showcases a neutralization assay measuring serum efficacy in neutralizing SARS-CoV-2 viruses. It involves pseudotyped viruses, serum dilution, and...

Visualizing Dose-Dependent Spike Protein Uptake with Quantum Dot Conjugates

0 Views •

2026

Source: Tran, B. N., et. al. High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells. J. Vis. Exp. (2022)This video demonstrates the use of quantum dot–conjugated spike protein (QD-Spike) to visualize dose-dependent viral entry in ACE2-GFP–expressing cells. Confocal imaging captures the internalization of QD-Spike via receptor-mediated endocytosis, modeling early coronavirus entry.

Bioreporter Assay: A Sensitive Technique using a Bioluminescent Reporter System to Detect SARS-CoV-2 Antibodies

0 Views •

2025

In this video, we show the HiBit-RBD bioreporter system-based assay for detecting SARS-CoV-2 neutralizing antibodies. This system targets the viral RBD domain by using a bioluminescent reporter system containing HiBiT fused to the RBD domain.

View All Results

FAQs

Related Topics